Why the study?
Do ergometrine and apomorphine act as selective antagonists of dopamine in the canine renal vasculature?
Do ergometrine and apomorphine act as selective antagonists of dopamine in the canine renal vasculature?
Ergometrine and apomorphine can be used as specific blocking agents at vascular dopamine receptors in the canine renal vasculature, with ergometrine being preferred.
Answers are grounded in this paper and cite their sources.
Does not support clinical use; extends pharmacological tools for dopamine receptor studies in canine renal vasculature.
1 Increases in renal blood flow were produced by intra-arterial injections of dopamine (5-50 mug) in anaesthetized dogs pretreated with alpha- and beta-adrenoceptor antagonists.2 Intra-arterial administration of ergometrine (0.5 mg) or apomorphine (1 mg) produced a depression of the renal dilator responses to dopamine, without affecting renal dilatations in response to intra-arterial acetylcholine (0.1-1 mug) or histamine (2-50 mug).3 The depression of dopamine responses lasted 10-15 min, and was greater with ergometrine than with apomorphine.4 It is concluded that both ergometrine and apomorphine can be used as specific blocking agents at vascular dopamine receptors. Ergometrine is the preferred drug for this purpose.
No takes yet. Share an insight, caveat, or question.
Bell et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: